| Central carbon metabolism in cancer |
1.95 |
2.71e-2 |
67/70 (95.71%) |
SLC7A5;SLC2A1;MYC;...
|
| Nitrogen metabolism |
1.77 |
4.75e-2 |
16/17 (94.12%) |
CA9;CA2;CA12;...
|
| Bladder cancer |
1.76 |
4.37e-2 |
40/41 (97.56%) |
VEGFA;HBEGF;MYC;...
|
| Proteoglycans in cancer |
1.75 |
3.93e-2 |
172/205 (83.9%) |
VEGFA;HBEGF;FLNB;...
|
| Basal cell carcinoma |
1.75 |
3.94e-2 |
41/63 (65.08%) |
GADD45B;CDKN1A;GADD45A;...
|
| Parathyroid hormone synthesis, secretion and action |
1.73 |
4.29e-2 |
98/106 (92.45%) |
PDE4D;HBEGF;CDKN1A;...
|
| Pancreatic cancer |
1.73 |
4.38e-2 |
75/76 (98.68%) |
VEGFA;GADD45B;TGFA;...
|
| Rap1 signaling pathway |
1.71 |
4.75e-2 |
184/210 (87.62%) |
VEGFA;ID1;MET;...
|
| Neurotrophin signaling pathway |
1.71 |
4.52e-2 |
107/119 (89.92%) |
ABL1;BDNF;ATF4;...
|
| PI3K-Akt signaling pathway |
1.71 |
4.41e-2 |
317/354 (89.55%) |
DDIT4;VEGFA;AREG;...
|
| Insulin secretion |
1.70 |
4.23e-2 |
75/86 (87.21%) |
SLC2A1;ATF4;ADCY1;...
|
| Thyroid cancer |
1.69 |
4.44e-2 |
36/37 (97.3%) |
GADD45B;MYC;CDKN1A;...
|
| Graft-versus-host disease |
1.67 |
4.64e-2 |
32/42 (76.19%) |
PRF1;IL1A;HLA-C;...
|
| Hippo signaling pathway |
1.65 |
4.81e-2 |
120/186 (64.52%) |
AREG;CCN2;MYC;...
|
| Type II diabetes mellitus |
1.65 |
4.78e-2 |
42/46 (91.3%) |
PIK3R1;PKM;PIK3CA;...
|
| Primary bile acid biosynthesis |
-1.69 |
1.94e-2 |
15/17 (88.24%) |
CYP46A1;AKR1D1;AMACR;...
|
| Malaria |
-1.70 |
1.76e-2 |
44/50 (88%) |
THBS4;SDC2;HBB;...
|
| Metabolism of xenobiotics by cytochrome P450 |
-1.73 |
1.45e-2 |
49/77 (63.64%) |
GSTO1;GSTM2;HPGDS;...
|
| Steroid hormone biosynthesis |
-1.75 |
9.04e-3 |
43/61 (70.49%) |
HSD17B3;CYP21A2;CYP1A1;...
|
| Nicotinate and nicotinamide metabolism |
-1.76 |
8.12e-3 |
25/35 (71.43%) |
ENPP1;NAMPT;NNT;...
|
| Valine, leucine and isoleucine degradation |
-1.77 |
7.62e-3 |
42/48 (87.5%) |
PCCA;HADH;BCKDHB;...
|
| Butanoate metabolism |
-1.79 |
5.75e-3 |
23/28 (82.14%) |
BDH1;GAD1;HADH;...
|
| Staphylococcus aureus infection |
-1.79 |
6.33e-3 |
72/95 (75.79%) |
DSG1;KRT16;FGG;...
|
| Proteasome |
-1.83 |
3.91e-3 |
44/46 (95.65%) |
PSMA7;PSMD11;PSMB5;...
|
| Cholesterol metabolism |
-1.86 |
1.76e-3 |
44/50 (88%) |
ANGPTL8;APOA4;ANGPTL3;...
|
| Spliceosome |
-1.87 |
2.01e-3 |
101/150 (67.33%) |
SNRPF;RBM8A;SYF2;...
|
| Peroxisome |
-1.88 |
2.34e-3 |
72/82 (87.8%) |
PIPOX;NUDT7;HMGCL;...
|
| PPAR signaling pathway |
-1.90 |
1.41e-3 |
66/74 (89.19%) |
ACSL4;SLC27A5;ME1;...
|
| Retinol metabolism |
-1.91 |
1.76e-3 |
41/68 (60.29%) |
ADH5;CYP2C9;ALDH1A3;...
|
| Terpenoid backbone biosynthesis |
-1.95 |
0.00e+0 |
18/22 (81.82%) |
PDSS1;ACAT2;MVD;...
|
| Steroid biosynthesis |
-2.08 |
0.00e+0 |
19/20 (95%) |
LIPA;HSD17B7;NSDHL;...
|
| Complement and coagulation cascades |
-2.28 |
0.00e+0 |
76/85 (89.41%) |
F13B;C8B;F2;...
|
